Reviewed by Julian Douwes M.D., Chief Medical Officer, Klinik St. Georg
Intravenous therapy delivers antibiotics, micronutrients, and photobiomodulation directly into the bloodstream. For patients with chronic or disseminated Lyme disease, IV delivery can achieve tissue concentrations that oral treatment cannot reach, making it a central component of intensive treatment protocols.
IV antibiotics: Ceftriaxone and IV doxycycline achieve significantly higher blood and tissue concentrations than oral formulations. IV antibiotics are standard of care for neuroborreliosis, Lyme carditis, and cases that have not responded to oral therapy.
IV micronutrients: High-dose vitamin C, glutathione, NAD+, and magnesium support immune function, reduce oxidative stress, and aid detoxification during intensive treatment.
IV laser therapy: Intravascular laser blood irradiation (ILBI) uses low-level light energy delivered directly into the bloodstream to modulate immune function and improve microcirculation.
Oral medications must pass through the gastrointestinal tract, where absorption is variable and subject to first-pass metabolism in the liver. This limits how much active drug reaches systemic circulation and, ultimately, infected tissues.
Intravenous delivery bypasses these barriers entirely. The medication enters the bloodstream at full concentration and distributes to tissues within minutes. For Lyme disease, where Borrelia can sequester in joints, the central nervous system, and collagen-rich tissues, achieving adequate drug concentrations in these compartments is often the difference between treatment success and failure.
Key pharmacokinetic advantages of IV delivery:
IV antibiotics are indicated when Lyme disease has disseminated beyond what oral therapy can adequately reach, or when oral treatment has failed to produce clinical improvement.
Ceftriaxone (typically 2 g daily for 14–28 days) is the most widely used IV antibiotic for Lyme disease. It crosses the blood-brain barrier effectively, achieves high concentrations in joint and cardiac tissue, and has decades of clinical evidence supporting its use in neuroborreliosis and Lyme arthritis that has not responded to oral therapy.
IV doxycycline may be used when ceftriaxone is contraindicated, such as in patients with cephalosporin allergy or biliary complications. IV doxycycline achieves higher and more consistent serum levels than its oral counterpart.
When IV antibiotics are typically indicated:
At Klinik St. Georg, IV antibiotics are timed strategically alongside hyperthermia sessions. Elevated core body temperature increases blood flow and tissue perfusion, potentially enhancing antibiotic distribution to compartments that are difficult to reach at normal body temperature.
Chronic Lyme disease places extraordinary demands on the body. Persistent infection, chronic inflammation, and the metabolic cost of immune activation deplete essential nutrients. IV micronutrient therapy replenishes these directly, at concentrations that oral supplementation cannot achieve.
High-dose vitamin C (typically 15–50 g per infusion) functions as an immune modulator and antioxidant at pharmacological doses. At these concentrations, vitamin C supports immune cell function, reduces oxidative damage from chronic inflammation, and may help manage Herxheimer-like reactions during antimicrobial treatment.
Glutathione is the body's primary intracellular antioxidant and a critical component of the detoxification pathway. Chronic Lyme patients frequently show depleted glutathione levels. IV glutathione supplementation supports the liver's ability to process bacterial toxins released during treatment and reduces oxidative stress.
NAD+ (nicotinamide adenine dinucleotide) is essential for cellular energy production and DNA repair. IV NAD+ infusions aim to restore cellular energy metabolism in patients whose mitochondrial function has been compromised by chronic infection and inflammation. Patients often report improved energy and mental clarity following NAD+ infusions.
Magnesium supports muscle and nerve function, both of which are commonly affected in Lyme disease. IV magnesium can also help reduce cardiac arrhythmias in patients with Lyme carditis and supports the enzymatic processes involved in detoxification.
Intravascular laser blood irradiation (ILBI) is a form of photobiomodulation in which a thin fiber-optic probe is inserted into a peripheral vein. Low-level laser light, typically in the red or near-infrared spectrum, is delivered directly to the blood as it flows past the probe.
Proposed mechanisms of action:
ILBI has been used in European clinical medicine for decades, particularly in Germany, Austria, and Russia. While large-scale randomized trials specific to Lyme disease are limited, the therapy is well-tolerated, has a strong safety profile, and is used as a supportive modality within the integrative protocol at Klinik St. Georg.
At Klinik St. Georg, IV therapies are not administered in isolation. They are coordinated within a structured treatment sequence that includes whole-body hyperthermia.
Before hyperthermia: IV micronutrients, particularly glutathione, vitamin C, and magnesium, are administered to prepare the body for the metabolic demands of elevated core temperature. Adequate hydration and electrolyte balance are established through IV fluids.
During or immediately after hyperthermia: IV antibiotics may be timed to coincide with or immediately follow hyperthermia sessions. The rationale is that elevated body temperature increases tissue perfusion and may increase bacterial metabolic activity, making organisms more susceptible to antibiotic killing during this window.
Post-treatment recovery: Additional IV support, including detoxification agents and micronutrients, helps the body process the bacterial die-off that can follow effective treatment and manage the associated Herxheimer-like reactions.
All IV therapies at Klinik St. Georg are administered under direct medical supervision with continuous monitoring.
A balanced assessment of antibiotic therapy for Lyme disease, including when oral and IV antibiotics are most effective.
How antibiotics, hyperthermia, apheresis, and immune support come together in one coordinated treatment protocol.
How whole-body hyperthermia targets Borrelia at the temperature threshold where it becomes structurally unstable.
A consultation can help determine whether IV-based treatment is appropriate for your situation and how it might fit within a comprehensive treatment plan.
Request a case review